 |
|
Serum Triglycerides in Coronary Artery Disease
MARGARET J. ALBRINK, M.D.;
EVELYN B. MAN, Ph.D.
AMA Arch Intern Med. 1959;103(1):4-8.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
The identification of cholesterol as a constituent of atheromatous plaques has aroused recurrent waves of suspicion that lipid metabolism is in some way responsible for the development of atherosclerosis and coronary artery disease. Lipids are transported in serum as constituents of three major classes of compounds: cholesterol and its esters, phospholipids, and triglycerides or neutral fat. Most investigations in recent years have centered about the notion that serum cholesterol plays a causative role in the development of coronary artery disease in spite of numerous studies focusing attention on triglycerides. Included in these studies are reports of increased turbidity, increased and prolonged chylomicronemia, and increased ratio of β- to  -lipoproteins. Although triglycerides rather than cholesterol are chiefly responsible for turbidity of serum and constitute an important fraction of β-lipoproteins, the quantitative estimation of triglycerides has been largely neglected in studies of serum lipids in coronary artery disease.
The present research was
. . . [Full Text PDF of this Article]
Author Affiliations
New Haven, Conn.
From the Department of Internal Medicine, Yale University School of Medicine, and the Medical Service, the Grace-New Haven Community Hospital.
Footnotes
Submitted for publication July 11, 1958.
Presented at the 71st annual meeting of the Association of American Physicians, Atlantic City, N. J., May 6, 1958.
This investigation was supported (in part) by research Grant H-3498 from the National Heart Institute and research Grant A-392 from the Institute of Arthritis and Metabolic Diseases, Public Health Service.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
